Hip osteoarthritis: follow-up of patients treated with intra-articular hyaluronic acid
Official title: Clinical Follow-up Study of Patients With Hip Osteoarthritis Treated With Intra-Articular Hyaluronic Acid
Run by Meiji Pharma Spain S.A. · NCT07883395 · Data updated 2026-11-12
This study follows adults over 40 with symptomatic hip OA who are already receiving hyaluronic acid injections to see how they fare in routine clinical practice in Spain.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Meiji Pharma Spain S.A. Industry-sponsored |
| Locations | 4 sites (Madrid and 3 other locations) |
| Status | Recruiting |
| Started | January 29, 2026 |
| Main results expected | April 2027 |
| Study ends | April 2027 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT07883395 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 40 with at least 1 year of symptomatic hip OA, radiographic KOA grade II-III, and currently receiving intra-articular hyaluronic acid.
✕Probably not a fit
Patients without ongoing hyaluronic acid treatment or with factors outside the eligibility criteria may not experience documented benefits from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects real-world data from adults aged 40 and older with hip osteoarthritis treated with intra-articular hyaluronic acid in several Spanish hospitals. Participants must have had symptoms for at least a year, radiographic KOA grades II–III, and a WOMAC score above 15, among other criteria. The investigation aims to document outcomes in standard clinical use rather than test an intervention. Data are drawn from patients treated within Traumatology and Rehabilitation departments of participating centers. The study is sponsored by Meiji Pharma Spain S.A. with academic and hospital collaborators.
Why it matters
Potential benefit: If successful, the study could clarify how intra-articular hyaluronic acid performs in real-world hip OA care and inform future treatment decisions.
How similar studies have gone: Observational real-world studies of hyaluronic acid for hip OA have yielded varied results but contribute valuable context for routine use.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: \>40 years at the time of study inclusion * Preserved gait capability, with or without assistive devices * Symptomatic hip arthropathy with a disease evolution of at least 1 year. * Radiographic Kellgren-Lawrence grade II-III documented within the 12 months prior to study entry * Total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score \>15 * Patient currently receiving intra-articular hyaluronic acid treatment within 3 months prior to study inclusion Exclusion Criteria: * Refusal to provide written informed consent * Females who are pregnant, breastfeeding, or not using effective contraception * Body Mass Index (BMI) ≥ 30 kg/m² * Presence of other chronic or autoimmune diseases that could interfere with clinical evaluation * History of hypersensitivity or allergy to hyaluronic acid or its derivatives * Prior administration of intra-articular platelet-rich plasma (PRP) or intra-articular corticosteroids within 3 months, or intra-articular hyaluronic acid within 6 months prior to study entry
Where it's running
-
Hospital Universitario de La Princesa
Madrid, Spain Recruiting -
Hospital Universitario de La Princesa
Madrid, Spain Recruiting -
QuironSalud. Hospital Juan Bravo
Madrid, Spain Recruiting -
Hospital Provincial Nuestra Señora de Gracia
Zaragoza, Spain Not yet recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Non-weight bearing treatment for hip joint pain and osteoarthritis
This study is testing if non-weight bearing walking can help people with hip osteoarthritis and joint pain feel better and stop their condition from getting worse.
-
Choose to Move Replacement Ready for OA patients waiting for hip or knee replacement
This program tests a tailored, online version of a 3-month activity and social-connection plan for older adults with hip or knee osteoarthritis who are waiting for joint replacement surgery to see if it improves physical activity and health while they wait.
-
Tipmed™ Primary Hip Prosthesis: 24-Month Post-Market Follow-Up in Adults
This PMCF study tests the safety and 24‑month performance of the Tipmed hip prosthesis in adults undergoing primary hip replacement.
-
PENG nerve block with or without pulsed radiofrequency for chronic hip osteoarthritis pain
The study will try adding pulsed radiofrequency to a PENG nerve block to see if it reduces pain for longer in people with chronic hip osteoarthritis who still have significant pain despite conservative treatment.
-
Virtual reality versus traditional relaxation to ease pain and improve sleep after hip or knee replacement
This will test whether relaxation using virtual reality or traditional relaxation works better to reduce pain and improve sleep in adults after hip or knee replacement.
-
Herbal combination (Boswellia, turmeric, grape extract) for hip or knee osteoarthritis
This study will test whether a daily herbal supplement containing Boswellia serrata, turmeric (curcumin), and grape extract (Vitis vinifera) reduces pain and improves function in adults with hip or knee osteoarthritis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.